anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

129,961-130,020 of 319,975

filter-aware
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
127
The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
129
The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
131
Uses direct quotes from the company's own SEC filings to highlight hypocrisy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
132
Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
133
Uses CEO quote to undermine management credibility.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
134
Uses testimonial quotes to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
135
Uses authority-citation framework to undermine the company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
136
Uses highlighted quotes to emphasize negative sentiment from industry experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
137
Uses expert quotes to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
138
Uses direct quotes from KOLs to undermine the company's product launch narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
139
The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
140
Uses expert testimony to undermine company narrative regarding product success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
141
The slide uses direct quotes from former employees to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
142
Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
143
Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
144
Uses quotes from KOLs and former users to frame the company as a 'one-trick pony' facing inevitable decline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
145
The slide uses expert quotes to frame the company's strategic pivot as a sign of desperation and loss of identity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
146
Uses yellow highlighting to emphasize key claims of deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
147
Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
148
Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
150
Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
151
Uses expert quotes to undermine the company's core product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
152
Uses KOL testimonials to highlight a technical contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
153
Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
154
Uses direct quotes from KOLs to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
155
The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
156
The slide uses historical data to undermine the company's 'innovation' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
158
Uses a series of quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
159
Uses expert quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
161
The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
162
The slide uses expert testimony to undermine the credibility of the company's clinical research and growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
163
Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
165
Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
166
The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
167
Uses multiple KOL quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
169
Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
172
Uses a direct quote from a KOL to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
173
Uses expert testimonials to debunk company growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
174
Features highlighted text blocks in yellow to emphasize critical quotes from former executives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
175
Uses expert testimony to frame the company's situation as dire.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
183
Uses expert testimony to debunk market optimism regarding M&A.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
184
The slide uses expert testimony to debunk the bull case of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
185
The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit